4
Changes in Ownership
SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-20-034288
Options or other derivatives
- Director acquired 6,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| VAN NOSTRAND ROBERT L Director | 2020-03-12 | Grant or award · Stock Option (Right to Buy) | +6,500 | 6,500 | D | ||
Loading xslF345X03/tm2012902-4_form4.xml…